Cargando…
Hyperglycemia may alter cytokine production and phagocytosis by means other than hyperosmotic stress
In the previous issue of Critical Care, Otto and colleagues used in vitro studies to explore the theory that immunomodulation, by correction of hyperglycemia, may be a contributing factor to the reported efficacy of intensive insulin therapy (IIT) in critically ill patients. They suggested that hype...
| Autor principal: | |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592746/ https://www.ncbi.nlm.nih.gov/pubmed/18973646 http://dx.doi.org/10.1186/cc7012 |